Protein analysis Protoarray
Tuesday, 16 September, 2008
Invitrogen Corporation has launched the ProtoArray Human Protein Microarray v4.1 which enables customers to screen biological samples or labeled probe of interest against approximately 8,200 unique human proteins in as little as one day. This technology has a broad range of applications - identification of novel protein biomarkers specific for infectious diseases, cancers, and autoimmune diseases; mapping protein-protein interactions important to biochemical pathways; identification of kinase/ ubiquitin ligase substrates for target discovery and validation; antibody specificity profiling for research and therapeutic antibody development; and small molecule-protein radioligand profiling for drug candidate selection and development Invitrogen Tel: 1800 331 627 www.invitrogen.com/protoarray.
Single-cell sequencing capability boosted in South Australia
The South Australian Genomics Centre has become the first certified service provider in...
Biomaterial helps to reverse aging in the heart
The discovery could open the door to therapies that rejuvenate the heart by changing its cellular...
mRNA used to force HIV out of hiding
Using the same technology behind mRNA COVID-19 vaccines, researchers have discovered a way to...
